Product Recalls in Montana

Product recalls affecting Montana — including food, drugs, consumer products, medical devices, and vehicles distributed to Montana. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,552 recalls have been distributed to Montana in the last 12 months.

48,326 total recalls
2,552 in last 12 months

Showing 38613880 of 13,407 recalls

DrugAugust 2, 2021· Macleods Pharma Usa Inc

Recalled Item: Clopidogrel Tablets Recalled by Macleods Pharma Usa Inc Due to Presence of...

The Issue: Presence of foreign matter

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 2, 2021· Akorn, Inc.

Recalled Item: Artificial Tears Ointment Recalled by Akorn, Inc. Due to Non-Sterility - OOS...

The Issue: Non-Sterility - OOS sterility testing observed during 12-month controlled...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 2, 2021· Je Dois Lavoir LLC

Recalled Item: 365 SKINNY High Intensity Capsules Recalled by Je Dois Lavoir LLC Due to...

The Issue: Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugJuly 30, 2021· Noven Pharmaceuticals Inc

Recalled Item: Combipatch (estradiol/norethindrone acetate transdermal system) 0.05/0.14 mg...

The Issue: Failed Stability Specifications; out of specification for shear.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 30, 2021· Noven Pharmaceuticals Inc

Recalled Item: Combipatch (estradiol/norethindrone acetate transdermal system) 0.05/0.25 mg...

The Issue: Failed Stability Specifications; out of specification for shear.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 30, 2021· Custopharm, Inc.

Recalled Item: FLUDARABINE PHOSPHATE FOR INJECTION Recalled by Custopharm, Inc. Due to Lack...

The Issue: Lack of Assurance of Sterility: the manufacturing firm had microbial...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 29, 2021· Teva Pharmaceuticals USA

Recalled Item: Cyclobenzaprine Hydrochloride Tablets Recalled by Teva Pharmaceuticals USA...

The Issue: CGMP Deviations: Out of specification (OOS) test result for Total Aerobic...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 29, 2021· PAI Holdings, LLC. dba Pharmaceutical Associates Inc

Recalled Item: Nystatin Oral Suspension Recalled by PAI Holdings, LLC. dba Pharmaceutical...

The Issue: Lack of CGMP: This recall is being carried out due to potential for carry...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 29, 2021· Teva Pharmaceuticals USA

Recalled Item: Haloperidol Decanoate Injection 100 mg/mL Recalled by Teva Pharmaceuticals...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 29, 2021· Teva Pharmaceuticals USA

Recalled Item: Vecuronium Bromide for Injection 10 mg Recalled by Teva Pharmaceuticals USA...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 29, 2021· Novel Laboratories, Inc. d.b.a LUPIN

Recalled Item: GaviLyteTM - C PEG-3350 (240g) and Electrolytes for Oral Solution Recalled...

The Issue: Failed Stability Specification; Out of specification for Osmolarity

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 29, 2021· Teva Pharmaceuticals USA

Recalled Item: Metoclopramide Injection USP Recalled by Teva Pharmaceuticals USA Due to...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 29, 2021· Teva Pharmaceuticals USA

Recalled Item: Octreotide Acetate Injection 50 mcg/mL Recalled by Teva Pharmaceuticals USA...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 29, 2021· Teva Pharmaceuticals USA

Recalled Item: Idarubicin Hydrochloride Injection 20 mg/20 mL Recalled by Teva...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 29, 2021· Teva Pharmaceuticals USA

Recalled Item: Methylprednisolone Acetate Injectable Suspension USP Recalled by Teva...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 29, 2021· Teva Pharmaceuticals USA

Recalled Item: Octreotide Acetate Injection 1000 mcg/5mL Recalled by Teva Pharmaceuticals...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 29, 2021· Teva Pharmaceuticals USA

Recalled Item: Adenosine Injection Recalled by Teva Pharmaceuticals USA Due to Lack of...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 29, 2021· PAI Holdings, LLC. dba Pharmaceutical Associates Inc

Recalled Item: Ethosuximide Oral Solution USP 250 mg/5 mL Recalled by PAI Holdings, LLC....

The Issue: Lack of CGMP: This recall is being carried out due to potential for carry...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 29, 2021· Teva Pharmaceuticals USA

Recalled Item: Octreotide Acetate Injection 100 mcg/mL Recalled by Teva Pharmaceuticals USA...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 29, 2021· Teva Pharmaceuticals USA

Recalled Item: Alprostadil Injection USP Recalled by Teva Pharmaceuticals USA Due to Lack...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund